Genpact (G) Competitors $40.70 -0.41 (-1.00%) As of 01:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock G vs. CCRN, BR, GPN, JKHY, EXLS, WEX, MMS, PAY, EEFT, and WUShould you be buying Genpact stock or one of its competitors? The main competitors of Genpact include Cross Country Healthcare (CCRN), Broadridge Financial Solutions (BR), Global Payments (GPN), Jack Henry & Associates (JKHY), ExlService (EXLS), WEX (WEX), Maximus (MMS), Paymentus (PAY), Euronet Worldwide (EEFT), and Western Union (WU). Genpact vs. Its Competitors Cross Country Healthcare Broadridge Financial Solutions Global Payments Jack Henry & Associates ExlService WEX Maximus Paymentus Euronet Worldwide Western Union Genpact (NYSE:G) and Cross Country Healthcare (NASDAQ:CCRN) are related companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Which has more risk and volatility, G or CCRN? Genpact has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Does the media refer more to G or CCRN? In the previous week, Genpact had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 4 mentions for Genpact and 1 mentions for Cross Country Healthcare. Genpact's average media sentiment score of 0.65 beat Cross Country Healthcare's score of -0.50 indicating that Genpact is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genpact 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Do analysts prefer G or CCRN? Genpact currently has a consensus price target of $52.29, suggesting a potential upside of 28.47%. Cross Country Healthcare has a consensus price target of $17.93, suggesting a potential upside of 35.37%. Given Cross Country Healthcare's higher possible upside, analysts plainly believe Cross Country Healthcare is more favorable than Genpact.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genpact 0 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.38Cross Country Healthcare 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Is G or CCRN more profitable? Genpact has a net margin of 10.92% compared to Cross Country Healthcare's net margin of -0.70%. Genpact's return on equity of 22.15% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Genpact10.92% 22.15% 10.61% Cross Country Healthcare -0.70%1.72%1.24% Do institutionals & insiders hold more shares of G or CCRN? 96.0% of Genpact shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 3.1% of Genpact shares are held by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has higher valuation & earnings, G or CCRN? Genpact has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenpact$4.93B1.44$513.67M$3.0113.52Cross Country Healthcare$1.34B0.32-$14.56M-$0.26-50.94 SummaryGenpact beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks. Get Genpact News Delivered to You Automatically Sign up to receive the latest news and ratings for G and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding G and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart G vs. The Competition Export to ExcelMetricGenpactIT Services IndustryComputer SectorNYSE ExchangeMarket Cap$7.10B$309.43B$32.51B$21.93BDividend Yield1.64%1.79%3.16%3.56%P/E Ratio13.5433.94496.2629.64Price / Sales1.4442.842,025.79100.64Price / Cash11.4524.4035.0118.33Price / Book3.008.927.504.61Net Income$513.67M$365.88M$819.01M$1.01B7 Day Performance-2.82%5.40%2.13%0.13%1 Month Performance-9.37%14.18%10.91%2.27%1 Year Performance2.88%358.29%24,144.34%13.84% Genpact Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GGenpact4.3412 of 5 stars$40.70-1.0%$52.29+28.5%+3.8%$7.10B$4.93B13.54140,000Positive NewsCCRNCross Country Healthcare3.3529 of 5 stars$13.76-3.3%$17.93+30.3%+8.7%$450.78M$1.34B-52.928,205BRBroadridge Financial Solutions4.7958 of 5 stars$237.70+0.7%$261.50+10.0%+9.3%$27.84B$6.89B33.5315,000Positive NewsAnalyst UpgradeGPNGlobal Payments4.9614 of 5 stars$86.37+2.4%$103.75+20.1%-11.6%$20.95B$10.11B15.1027,000Options VolumeJKHYJack Henry & Associates4.7694 of 5 stars$151.17+1.2%$182.33+20.6%-18.9%$10.99B$2.38B24.237,400EXLSExlService4.8715 of 5 stars$43.97+0.5%$51.33+16.7%+9.7%$7.10B$1.84B30.5359,500Positive NewsWEXWEX4.5117 of 5 stars$160.40-0.1%$179.82+12.1%-24.6%$5.50B$2.63B20.286,500MMSMaximus2.5711 of 5 stars$89.17+1.2%$90.00+0.9%-0.2%$5.02B$5.31B16.4241,100Dividend AnnouncementPAYPaymentus3.423 of 5 stars$31.01-0.8%$37.00+19.3%+58.5%$3.88B$871.74M72.121,307Positive NewsEEFTEuronet Worldwide4.7972 of 5 stars$88.96-0.5%$122.83+38.1%-10.0%$3.65B$3.99B12.2010,600WUWestern Union4.0301 of 5 stars$8.01+0.8%$8.61+7.5%-31.6%$2.59B$4.21B3.039,100 Related Companies and Tools Related Companies Cross Country Healthcare Competitors Broadridge Financial Solutions Competitors Global Payments Competitors Jack Henry & Associates Competitors ExlService Competitors WEX Competitors Maximus Competitors Paymentus Competitors Euronet Worldwide Competitors Western Union Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:G) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genpact Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genpact With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
